Patents by Inventor Sandra Gendler

Sandra Gendler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antigens derived from the core protein of the human mammary epithelial mucin
    Publication number: 20050260604
    Abstract: An expression vector is used to express a polypeptide comprising the core protein of a human polymorphic epithelial mucin, which core protein is specifically bound by monoclonal antibody. SM3. The vector may be used to elicit an immune response in a subject, and to thereby immunize that subject against a disease.
    Type: Application
    Filed: January 29, 2004
    Publication date: November 24, 2005
    Inventors: Joyce Taylor-Papadimitriou, Sandra Gendler, Joy Burchell
  • Probe
    Publication number: 20020071830
    Abstract: An expression vector is used to express a polypeptide comprising the core protein of a human polymorphic epithelial mucin, which core protein is specifically bound by monoclonal antibody. SM3. The vector may be used to elicit an immune response in a subject, and to thereby immunize that subject against a disease.
    Type: Application
    Filed: December 5, 2000
    Publication date: June 13, 2002
    Inventors: Joyce Taylor-Papadimitriou, Sandra Gendler, Joy Burchell
  • Antigens derived from the core protein of the human mammary epithelial mucin
    Patent number: 6222020
    Abstract: Antigens are derived from the tandem repeat sequence of the core protein of a human polymorphic epithelial mucin. These antigens include a core protein epitope which is recognized by certain antibodies which also bind certain carcinoma antigens, but not fully processed HPEM glycoprotein as produced by the normal lactating human mammary gland.
    Type: Grant
    Filed: June 1, 1995
    Date of Patent: April 24, 2001
    Assignee: Imperial Cancer Research Technology Limited
    Inventors: Joyce Taylor-Papadimitriou, Sandra Gendler, Joy Burchell
  • Nucleic acid fragments encoding portions of the core protein of the human mammary epithelial mucin
    Patent number: 6054438
    Abstract: Nucleic acid fragments are described which can be used as probes for detecting one of the strands of the DNA tandem repeat sequence in the gene encoding the core protein of human polymorphic epithelial mucin, or incorporated into an expression vector to encode a portion of the mucin core protein to be used for immunization purposes.
    Type: Grant
    Filed: June 1, 1995
    Date of Patent: April 25, 2000
    Assignee: Imperial Cancer Research Technology Limited
    Inventors: Joyce Taylor-Papadimitriou, Sandra Gendler, Joy Burchell
  • Antibody against human mucin core protein and method of preparing and using same
    Patent number: 5683674
    Abstract: Antibodies which bind to the core protein of the human polymorphic epithelial mucin glycoprotein are useful in the diagnosis of cancer.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: November 4, 1997
    Assignee: Imperial Cancer Research Technology Ltd.
    Inventors: Joyce Taylor-Papadimitriou, Sandra Gendler, Joy Burchell